title: Awareness in cardiothoracic anaesthetic practice - where now after NAP5?
authors.affiliation: University Hospital Southampton NHS Foundation Trust, Southampton, UK. david.smith@uhs.nhs.uk.
authors.forename: D
authors.initials: D
authors.lastname: Smith
authors.forename: N G
authors.initials: NG
authors.lastname: Goddard
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D018712:Analgesics, Non-Narcotic / Q000494:pharmacology*; D000767:Anesthesia, Epidural; D000768:Anesthesia, General; D001364:Awareness / Q000187:drug effects*; D020927:Dexmedetomidine / Q000494:pharmacology*; D004569:Electroencephalography; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D007431:Intraoperative Complications / Q000517:prevention & control*; D008297:Male; D016343:Monitoring, Intraoperative; D010149:Postoperative Pain / Q000517:prevention & control*; D012121:Respiration, Artificial / Q000379:methods*
chemical_list: D000316:Adrenergic alpha-Agonists; D018712:Analgesics, Non-Narcotic; D006993:Hypnotics and Sedatives; D020927:Dexmedetomidine